As reported by NHS England, streamlined guidance has been published on recording appointments in General Practice, affecting key performance indicators and evaluations by commissioners and the CQC
Continuous improvement to the quality of GP appointment data (GPAD) reporting will enable a better understanding of how appointments are planned and managed locally. This will help inform local operational business functions and national policy and planning decisions, as well as to monitor progress against the Primary Care Access Recovery Plan, all with the aim of delivering for patients.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment